Diagnostic dilemmas in Fabry disease: a case series study on GLA mutations of unknown clinical significance

Fabry disease' (FD) phenotype is heterogeneous: alpha‐galactosidase A gene mutations (GLA) can lead to classical or non‐classical FD, or no FD. The aim of this study is to describe pitfalls in diagnosing non‐classical FD and assess the diagnostic value of plasma globotriaosylsphingosine. This i...

Full description

Saved in:
Bibliographic Details
Published in:Clinical genetics 2015-08, Vol.88 (2), p.161-166
Main Authors: Smid, B.E., Hollak, C.E.M., Poorthuis, B.J.H.M., van den Bergh Weerman, M.A., Florquin, S., Kok, W.E.M., Lekanne Deprez, R.H., Timmermans, J., Linthorst, G.E.
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
alpha-Galactosidase - genetics
Biopsy
cardiac variant
Cardiomyopathy, Hypertrophic, Familial - genetics
diagnosis
Fabry disease
Fabry Disease - diagnosis
Fabry Disease - genetics
Female
Genetic disorders
Globosides - blood
Histology
Humans
Male
Middle Aged
Mutation
Mutation - genetics
phenotype
Plasma
renal variant
Retrospective Studies
screening
variant of unknown significance (VUS)
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Fabry disease' (FD) phenotype is heterogeneous: alpha‐galactosidase A gene mutations (GLA) can lead to classical or non‐classical FD, or no FD. The aim of this study is to describe pitfalls in diagnosing non‐classical FD and assess the diagnostic value of plasma globotriaosylsphingosine. This is a case series study. Family 1 (p.A143T) presented with hypertrophic cardiomyopathy (HCM), absent classical FD signs, high residual alpha‐galactosidase A activity (AGAL‐A) and normal plasma globotriaosylsphingosine. Co‐segregating sarcomeric mutations were found. Cardiac biopsy excluded FD. In family 2 (p.P60L), FD was suspected after kidney biopsy in a female with chloroquine use. Males had residual AGAL‐A, no classical FD signs and minimally increased plasma globotriaosylsphingosine, indicating that p.P60L is most likely non‐pathogenic. Non‐specific complications and histology can be explained by chloroquine and alternative causes. Males of two unrelated families (p.R112H) show AGAL‐A 50 nmol/l). Histological evidence suggests a variable penetrance of this mutation. Patients with GLA mutations and non‐specific findings such as HCM may have non‐classical FD or no FD. Other (genetic) causes of FD‐like findings should be excluded, including medication inducing FD‐like storage. Plasma globotriaosylsphingosine may serve as a diagnostic tool, but histology of an affected organ is often mandatory.
ISSN:0009-9163
1399-0004
DOI:10.1111/cge.12449